The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries.

Alzheimer's disease cross‐cultural validation dementia differential item functioning diversity functional decline instrumental activities of daily living item response theory

Journal

Alzheimer's & dementia (Amsterdam, Netherlands)
ISSN: 2352-8729
Titre abrégé: Alzheimers Dement (Amst)
Pays: United States
ID NLM: 101654604

Informations de publication

Date de publication:
2020
Historique:
received: 14 11 2019
revised: 16 01 2020
accepted: 23 01 2020
entrez: 19 5 2020
pubmed: 19 5 2020
medline: 19 5 2020
Statut: epublish

Résumé

To understand the potential influence of diversity on the measurement of functional impairment in dementia, we aimed to investigate possible bias caused by age, gender, education, and cultural differences. A total of 3571 individuals (67.1 ± 9.5 years old, 44.7% female) from The Netherlands, Spain, France, United States, United Kingdom, Greece, Serbia, and Finland were included. Functional impairment was measured using the Amsterdam Instrumental Activities of Daily Living (IADL) Questionnaire. Item bias was assessed using differential item functioning (DIF) analysis. There were some differences in activity endorsement. A few items showed statistically significant DIF. However, there was no evidence of meaningful item bias: Effect sizes were low (Δ The results imply a limited bias for age, gender, education, and culture in the measurement of functional impairment. This study provides an important step in recognizing the potential influence of diversity on primary outcomes in dementia research.

Identifiants

pubmed: 32420446
doi: 10.1002/dad2.12021
pii: DAD212021
pmc: PMC7219786
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e12021

Subventions

Organisme : The Dunhill Medical Trust
ID : R380R/1114
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.

Déclaration de conflit d'intérêts

The Amsterdam IADL Questionnaire was developed by S.A.M.S. and P.S., who were involved in the conception of the present study. The other authors report no conflict of interests.

Références

J Alzheimers Dis. 2017;58(2):425-434
pubmed: 28453478
Lancet Psychiatry. 2016 Feb;3(2):179-86
pubmed: 26683239
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Alzheimers Dement (N Y). 2018 Feb 13;4:64-75
pubmed: 29955653
Health Qual Life Outcomes. 2012 Oct 30;10:130
pubmed: 23110491
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
J Geriatr Psychiatry Neurol. 2013 Dec;26(4):244-50
pubmed: 24212244
J Gerontol B Psychol Sci Soc Sci. 2002 Sep;57(5):S275-84
pubmed: 12198107
Neurodegener Dis Manag. 2014;4(5):393-400
pubmed: 25405652
Dement Neuropsychol. 2014 Apr-Jun;8(2):95-98
pubmed: 29213888
Neuroepidemiology. 2013;41(1):35-41
pubmed: 23712106
Alzheimers Dement (N Y). 2016 Mar 03;2(2):82-92
pubmed: 29067295
Curr Alzheimer Res. 2018;15(13):1261-1266
pubmed: 30251604
Aging Clin Exp Res. 2003 Dec;15(6):451-9
pubmed: 14959947
Alzheimer Dis Assoc Disord. 2011 Jul-Sep;25(3):187-95
pubmed: 21399486
J Aging Health. 2019 Dec;31(10):1748-1769
pubmed: 30141717
Med Care. 2004 Jan;42(1 Suppl):I37-48
pubmed: 14707754
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Lancet Neurol. 2018 Apr;17(4):335-346
pubmed: 29500152
Alzheimers Dement (Amst). 2017 Mar 31;8:26-35
pubmed: 28462387
J Clin Epidemiol. 2007 Apr;60(4):366-74
pubmed: 17346611
J Alzheimers Dis. 2018;62(3):1091-1111
pubmed: 29562540
Psychol Aging. 2009 Mar;24(1):116-28
pubmed: 19290743
J Nutr Health Aging. 2016;20(7):722-8
pubmed: 27499305
J Am Geriatr Soc. 2008 Jan;56(1):37-44
pubmed: 18028344
J Clin Epidemiol. 2015 Apr;68(4):435-41
pubmed: 25698408
PeerJ. 2017 Sep 28;5:e3839
pubmed: 28970969
Alzheimers Dement. 2015 Oct;11(10):1231-40
pubmed: 25598195
Acta Psychiatr Scand. 2014 Jan;129(1):63-72
pubmed: 23521526
Aging Ment Health. 2015 Jan;19(1):63-71
pubmed: 24831511
J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):7-12
pubmed: 19091706
Alzheimers Dement. 2019 Feb;15(2):292-312
pubmed: 30555031
BMJ Open. 2019 Feb 19;8(12):e021017
pubmed: 30782589
Annu Rev Clin Psychol. 2009;5:27-48
pubmed: 18976138
Alzheimers Dement. 2012 Nov;8(6):536-43
pubmed: 23102123
J Stat Softw. 2011 Mar 1;39(8):1-30
pubmed: 21572908
Int Psychogeriatr. 1997;9 Suppl 1:173-6; discussion 177-8
pubmed: 9447441
Dement Geriatr Cogn Disord. 2008;25(1):46-53
pubmed: 18025829
Ethn Health. 2000 Feb;5(1):67-78
pubmed: 10858941
PLoS One. 2019 Apr 9;14(4):e0215073
pubmed: 30964935

Auteurs

Mark A Dubbelman (MA)

Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands.

Merike Verrijp (M)

Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands.

David Facal (D)

Department of Developmental Psychology University of Santiago de Compostela A Coruña Spain.

Gonzalo Sánchez-Benavides (G)

Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.

Laura J E Brown (LJE)

Faculty of Biology Medicine and Health University of Manchester Manchester Academic Science Centre Manchester UK.

Wiesje M van der Flier (WM)

Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands.
Department of Epidemiology and Biostatistics Amsterdam UMC Amsterdam The Netherlands.

Hanna Jokinen (H)

Clinical Neurosciences Neurology University of Helsinki and Helsinki University Hospital Helsinki Finland.
Department of Psychology and Logopedics Faculty of Medicine University of Helsinki Finland.

Athene Lee (A)

Butler Hospital Warren Alpert Medical School of Brown University Providence Rhode Island.

Iracema Leroi (I)

Faculty of Biology Medicine and Health University of Manchester Manchester Academic Science Centre Manchester UK.

Cristina Lojo-Seoane (C)

Department of Developmental Psychology University of Santiago de Compostela A Coruña Spain.

Vuk Milošević (V)

Clinic of Neurology Clinical Center Niš Niš Serbia.

José Luís Molinuevo (JL)

Barcelonaβeta Brain Research Center (BBRC) Pasqual Maragall Foundation Barcelona Spain.

Arturo X Pereiro Rozas (AX)

Department of Developmental Psychology University of Santiago de Compostela A Coruña Spain.

Craig Ritchie (C)

University of Edinburgh Edinburgh UK.

Stephen Salloway (S)

Butler Hospital Warren Alpert Medical School of Brown University Providence Rhode Island.

Gemma Stringer (G)

Faculty of Biology Medicine and Health University of Manchester Manchester Academic Science Centre Manchester UK.

Stelios Zygouris (S)

School of Medicine Aristotle University of Thessaloniki Thessaloniki Greece.
Network Aging Research Heidelberg University Heidelberg Germany.

Bruno Dubois (B)

Department of Neurology Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) of the Pitié-Salpêtrière Hospital & ARAMIS Sorbonne University Inria de Paris Institut du cerveau et de lamoelle épinière (ICM) Paris France.

Stéphane Epelbaum (S)

Department of Neurology Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A) of the Pitié-Salpêtrière Hospital & ARAMIS Sorbonne University Inria de Paris Institut du cerveau et de lamoelle épinière (ICM) Paris France.

Philip Scheltens (P)

Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands.

Sietske A M Sikkes (SAM)

Alzheimer Center Amsterdam Department of Neurology Amsterdam Neuroscience Vrije Universiteit Amsterdam Amsterdam UMC Amsterdam The Netherlands.
Department of Epidemiology and Biostatistics Amsterdam UMC Amsterdam The Netherlands.

Classifications MeSH